VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMBC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AMBCAmbac Financial Group, Inc.
$6.13$269M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAMBCQuarterly Financials

Ambac Financial Group, Inc. (AMBC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ambac Financial Group, Inc. (AMBC) quarterly income statement — complete revenue, gross profit & net income history

AMBC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Revenue66.61M54.96M62.76M-85.19M70M51.04M49.55M73M72M61M57M195M80M29M120M53M52M50M95M87M
Revenue Growth %-4.86%7.68%26.65%-216.69%-2.77%-16.33%-13.07%-62.56%-10%110.34%-52.5%267.92%53.85%-42%26.32%-39.08%-17.46%-33.33%235.71%-4.76%
Medical Costs & Claims29.04M22.08M24.7M40.17M35.91M36.31M33.6M31M-66M14M27M-49M-348M-8M29M-15M-51M-26M8M9M
Medical Cost Ratio %43.61%40.18%39.36%-47.15%51.3%71.15%67.81%42.47%-91.67%22.95%47.37%-25.13%-435%-27.59%24.17%-28.3%-98.08%-52%8.42%10.34%
Gross Profit37.56M32.88M38.05M-125.35M34.09M14.73M15.95M42M138M47M30M244M428M37M91M68M103M76M87M78M
Gross Margin %56.39%59.82%60.64%147.15%48.7%28.85%32.19%57.53%191.67%77.05%52.63%125.13%535%127.59%75.83%128.3%198.08%152%91.58%89.66%
Gross Profit Growth %10.18%123.26%138.58%-398.46%-75.3%-68.67%-46.83%-82.79%-67.76%27.03%-67.03%258.82%315.53%-51.32%4.6%-12.82%615%28.81%146.52%1495.35%
Operating Expenses69.64M55.85M53.16M-64.51M54.85M29.48M19.19M58M72M59M59M70M86M31M87M87M83M92M69M91M
OpEx / Revenue %104.56%101.63%84.71%75.73%78.35%57.75%38.73%79.45%100%96.72%103.51%35.9%107.5%106.9%72.5%164.15%159.62%184%72.63%104.6%
Depreciation & Amortization9.75M9.74M9.18M-15.05M7.1M1.61M1.61M9M8M7M7M14M6M15M14M12M11M15M19M17M
Combined Ratio %148.16%141.8%124.07%28.57%129.65%128.9%106.54%121.92%8.33%119.67%150.88%10.77%-327.5%79.31%96.67%135.85%61.54%132%81.05%114.94%
Operating Income-32.08M-22.97M-15.11M-60.84M-20.76M-14.75M-3.24M-16M66M-12M-29M174M342M6M4M-19M20M-16M18M-13M
Operating Margin %-48.16%-41.8%-24.07%71.43%-29.65%-28.9%-6.54%-21.92%91.67%-19.67%-50.88%89.23%427.5%20.69%3.33%-35.85%38.46%-32%18.95%-14.94%
Operating Income Growth %-54.55%-55.77%-366.41%-280.28%-131.45%-22.91%88.83%-109.2%-80.7%-300%-825%1015.79%1610%137.5%-77.78%-46.15%118.69%52.94%106.29%88.26%
EBITDA-22.33M-13.23M-5.93M-75.9M-13.65M-13.13M-1.63M-7M74M-5M-22M188M348M21M18M-7M31M-1M37M4M
EBITDA Margin %-33.53%-24.08%-9.45%89.1%-19.5%-25.74%-3.28%-9.59%102.78%-8.2%-38.6%96.41%435%72.41%15%-13.21%59.62%-2%38.95%4.6%
Interest Expense6.18M5.57M5.45M5.63M3.75M0016M16M16M16M30M49M45M44M43M44M50M50M50M
Non-Operating Income-6.19M-5.57M-5.45M41.62M-3.75M000-18M-17M-16M-29M-49M-45M-43M-43M-43M-48M-51M-50M
Pretax Income-32.08M-22.97M-15.11M-60.84M-20.76M-14.75M-3.24M-16M68M-11M-29M173M342M6M3M-19M19M-18M19M-13M
Pretax Margin %-48.16%-41.8%-24.07%71.43%-29.65%-28.9%-6.54%-21.92%94.44%-18.03%-50.88%88.72%427.5%20.69%2.5%-35.85%36.54%-36%20%-14.94%
Income Tax-1.24M-2.17M-617K-10.92M-867K-30K130K01M2M4M-2M2M1M03M2M11M2M2M
Effective Tax Rate %3.87%9.45%4.08%17.95%4.18%0.2%-4.01%0%1.47%-18.18%-13.79%-1.16%0.58%16.67%0%-15.79%10.53%-61.11%10.53%-15.38%
Net Income-112.62M-72.7M-46.39M-548.45M-27.5M-750K20.07M-16M66M-13M-32M174M340M5M2M-22M17M-28M17M-14M
Net Margin %-169.09%-132.28%-73.92%643.83%-39.29%-1.47%40.5%-21.92%91.67%-21.31%-56.14%89.23%425%17.24%1.67%-41.51%32.69%-56%17.89%-16.09%
Net Income Growth %-309.48%-9593.2%-331.15%-3327.81%-141.67%94.23%162.72%-109.2%-80.59%-360%-1700%890.91%1900%117.86%-88.24%-57.14%115.74%20%106.07%87.33%
EPS (Diluted)-2.35-1.54-1.22-11.40-0.59-0.020.43-0.241.41-0.28-0.723.867.420.11-0.87-0.470.35-0.600.36-0.30
EPS Growth %-298.31%-7029.63%-383.72%-4647.92%-141.84%92.29%159.72%-106.22%-81%-354.55%17.24%921.28%2020%118.33%-341.67%-55.04%114.96%21.05%105.92%87.38%
EPS (Basic)-2.35-1.54-1.22-11.79-0.59-0.020.44-0.851.44-0.28-0.723.937.500.11-0.88-0.480.35-0.600.37-0.30
Diluted Shares Outstanding48.11M48.12M47.31M48.13M47.69M46.21M46.35M45.59M46.81M45.76M45.56M46.08M45.85M45.69M47.36M46.63M47.04M46.58M46.86M46.18M